A detailed history of Baxter Bros Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Baxter Bros Inc holds 51,043 shares of JNJ stock, worth $7.44 Million. This represents 1.09% of its overall portfolio holdings.

Number of Shares
51,043
Previous 52,857 3.43%
Holding current value
$7.44 Million
Previous $7.73 Million 7.08%
% of portfolio
1.09%
Previous 1.02%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$145.48 - $167.38 $263,900 - $303,627
-1,814 Reduced 3.43%
51,043 $8.27 Million
Q2 2024

Jul 15, 2024

SELL
$144.38 - $157.78 $620,112 - $677,665
-4,295 Reduced 7.52%
52,857 $7.73 Million
Q1 2024

Apr 26, 2024

SELL
$155.22 - $162.74 $11,175 - $11,717
-72 Reduced 0.13%
57,152 $9.04 Million
Q4 2023

May 17, 2024

BUY
$145.6 - $158.88 $111,820 - $122,019
768 Added 1.34%
57,920 $9.08 Million
Q4 2023

Feb 06, 2024

SELL
$145.6 - $158.88 $338,665 - $369,554
-2,326 Reduced 3.91%
57,224 $8.97 Million
Q3 2023

May 17, 2024

BUY
$155.75 - $174.48 $363,676 - $407,410
2,335 Added 4.09%
59,487 $9.27 Million
Q3 2023

Oct 23, 2023

SELL
$155.75 - $174.48 $183,162 - $205,188
-1,176 Reduced 1.94%
59,550 $9.27 Million
Q2 2023

Aug 14, 2023

BUY
$154.35 - $166.11 $98,320 - $105,812
637 Added 1.06%
60,726 $10.1 Million
Q1 2023

May 15, 2023

SELL
$151.05 - $180.26 $127,033 - $151,598
-841 Reduced 1.38%
60,089 $9.31 Million
Q4 2022

Jan 31, 2023

SELL
$160.2 - $179.79 $147,544 - $165,586
-921 Reduced 1.49%
60,930 $10.8 Million
Q3 2022

Nov 10, 2022

BUY
$161.33 - $179.52 $1.87 Million - $2.09 Million
11,616 Added 23.12%
61,851 $10.1 Million
Q2 2022

Jul 25, 2022

SELL
$168.19 - $186.01 $32,965 - $36,457
-196 Reduced 0.39%
50,235 $8.92 Million
Q1 2022

Apr 20, 2022

SELL
$158.14 - $179.59 $149,126 - $169,353
-943 Reduced 1.84%
50,431 $8.94 Million
Q4 2021

Jan 14, 2022

SELL
$155.93 - $173.01 $95,585 - $106,055
-613 Reduced 1.18%
51,374 $8.79 Million
Q3 2021

Oct 25, 2021

SELL
$161.5 - $179.47 $88,340 - $98,170
-547 Reduced 1.04%
51,987 $8.4 Million
Q2 2021

Aug 11, 2021

BUY
$159.48 - $171.07 $346,390 - $371,564
2,172 Added 4.31%
52,534 $8.65 Million
Q1 2021

Apr 23, 2021

BUY
$153.07 - $170.48 $99,954 - $111,323
653 Added 1.31%
50,362 $8.28 Million
Q4 2020

Jan 25, 2021

BUY
$137.11 - $157.38 $254,201 - $291,782
1,854 Added 3.87%
49,709 $7.82 Million
Q3 2020

Nov 05, 2020

BUY
$140.38 - $153.83 $60,082 - $65,839
428 Added 0.9%
47,855 $7.13 Million
Q2 2020

Jul 31, 2020

SELL
$128.81 - $155.51 $410,517 - $495,610
-3,187 Reduced 6.3%
47,427 $6.67 Million
Q1 2020

Apr 17, 2020

BUY
$111.14 - $153.99 $542,807 - $752,087
4,884 Added 10.68%
50,614 $6.64 Million
Q4 2019

Jan 10, 2020

SELL
$127.5 - $146.44 $56,865 - $65,312
-446 Reduced 0.97%
45,730 $6.67 Million
Q4 2019

Jan 09, 2020

SELL
$127.5 - $146.44 $180,285 - $207,066
-1,414 Reduced 2.97%
46,176 $4.83 Million
Q3 2019

Oct 21, 2019

BUY
$126.95 - $142.14 $58,523 - $65,526
461 Added 0.98%
47,590 $6.16 Million
Q2 2019

Jul 29, 2019

BUY
$131.15 - $144.24 $116,198 - $127,796
886 Added 1.92%
47,129 $6.56 Million
Q1 2019

Apr 22, 2019

BUY
$125.72 - $139.79 $154,384 - $171,662
1,228 Added 2.73%
46,243 $6.46 Million
Q4 2018

Jan 22, 2019

BUY
$122.84 - $147.84 $725,370 - $872,995
5,905 Added 15.1%
45,015 $5.81 Million
Q3 2018

Oct 11, 2018

SELL
$121.58 - $142.88 $255,196 - $299,905
-2,099 Reduced 5.09%
39,110 $5.4 Million
Q2 2018

Jul 17, 2018

SELL
$119.4 - $131.76 $87,878 - $96,975
-736 Reduced 1.75%
41,209 $5 Million
Q1 2018

May 16, 2018

SELL
$125.1 - $148.14 $1,501 - $1,777
-12 Reduced 0.03%
41,945 $5.38 Million
Q4 2017

Feb 01, 2018

SELL
$131.22 - $143.62 $158,644 - $173,636
-1,209 Reduced 2.8%
41,957 $5.86 Million
Q3 2017

Oct 16, 2017

BUY
$129.47 - $135.38 $5.59 Million - $5.84 Million
43,166
43,166 $5.61 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $381B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Baxter Bros Inc Portfolio

Follow Baxter Bros Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baxter Bros Inc, based on Form 13F filings with the SEC.

News

Stay updated on Baxter Bros Inc with notifications on news.